Page last updated: 2024-08-24

cilazapril, anhydrous and Coronary Disease

cilazapril, anhydrous has been researched along with Coronary Disease in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's14 (87.50)18.2507
2000's2 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gocer, H; Tavli, T1
Chappuis, F; Danchin, N; Emanuelsson, H; Foley, DP; Hermans, WR; Rensing, BJ; Rutsch, W; Serruys, PW; Tijssen, JG; Wijns, W1
Hattori, Y; Hayashi, Y; Imazu, M; Ito, M; Sekiguchi, Y; Ueda, H; Yamabe, T; Yamakido, M; Yamamoto, H1
Faxon, DP1
Foley, DP; Hermans, WR; Rensing, BJ; Serruys, PW1
Kozielska, E; Rettig-Stürmer, G; Tendera, M1
Berger, PB; Faxon, DP; Holmes, DR; Murphy, JG; O'Hanesian, MA; Ohman, EM; Schwartz, RS; Serruys, PW1
Abe, K; Isoyama, S; Nitta, Y; Tajima, M1
Kawai, S; Miyauchi, K; Okada, R; Yamaguchi, H1
Azar, A; Di Mario, C; Gil, R; Rames, A; Serruys, PW; Strikwerda, S1
Chappuis, F; Danchin, N; Deckers, JW; Emanuelsson, H; Foley, DP; Hermans, WR; Rensing, BJ; Rutsch, W; Serruys, PW; Wijns, W1
Chen, YD; Fuh, MM; Jeng, CY; Jeng, JR; Reaven, GM; Shen, DD; Sheu, WH; Shieh, SM1
Chesebro, JH; Ferrell, M; Fuster, V; Gold, HK1
Smalling, RW1
Dudczak, R; Gasic, S; Kleinbloesem, C; Korn, A1

Trials

10 trial(s) available for cilazapril, anhydrous and Coronary Disease

ArticleYear
Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to pr
    Journal of cardiovascular pharmacology, 1993, Volume: 22 Suppl 4

    Topics: Angioplasty, Balloon, Coronary; Cilazapril; Coronary Angiography; Coronary Disease; Coronary Vessels; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Regression Analysis; Risk Factors

1993
Effect of cilazapril on vascular restenosis after percutaneous transluminal coronary angioplasty.
    Coronary artery disease, 1995, Volume: 6, Issue:7

    Topics: Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Cilazapril; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Prospective Studies; Recurrence

1995
Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty
    Journal of the American College of Cardiology, 1995, Volume: 25, Issue:2

    Topics: Angioplasty, Balloon, Coronary; Aspirin; Cilazapril; Coronary Angiography; Coronary Disease; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Linear Models; Male; Middle Aged; Recurrence; Risk Factors; Time Factors; Treatment Outcome

1995
Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Resear
    American heart journal, 1994, Volume: 127, Issue:3

    Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cilazapril; Coronary Angiography; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence

1994
Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal
    Journal of the American College of Cardiology, 1996, Volume: 27, Issue:1

    Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Arterial Occlusive Diseases; Cilazapril; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Disease-Free Survival; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Recurrence; Statistics, Nonparametric; Treatment Outcome

1996
Long-term changes in the response of conductance and resistance coronary vessels to endothelium-dependent and independent vasodilators. A double-blind placebo-controlled study of the effect of a 6-month treatment with cilazapril.
    Italian heart journal : official journal of the Italian Federation of Cardiology, 2000, Volume: 1, Issue:10

    Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cilazapril; Coronary Circulation; Coronary Disease; Double-Blind Method; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Papaverine; Vascular Resistance; Vasodilator Agents

2000
Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The MERCATOR Study Group (Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Translumina
    Journal of the American College of Cardiology, 1992, Volume: 20, Issue:4

    Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Cineangiography; Coronary Angiography; Coronary Disease; Coronary Vessels; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Pyridazines; Recurrence; Time Factors; Treatment Outcome

1992
Improvement in metabolic risk factors for coronary heart disease associated with cilazapril treatment.
    American journal of hypertension, 1992, Volume: 5, Issue:8

    Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Body Mass Index; Cilazapril; Coronary Disease; Female; Heart Rate; Humans; Hypertension; Insulin; Lipids; Male; Middle Aged; Risk Factors; Triglycerides

1992
Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European
    Circulation, 1992, Volume: 86, Issue:1

    Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Coronary Disease; Double-Blind Method; Exercise Test; Follow-Up Studies; Humans; Placebos; Postoperative Complications; Pyridazines; Recurrence

1992
ACE inhibition with cilazapril improves myocardial perfusion to the ischemic regions during exercise: a pilot study.
    Journal of cardiovascular pharmacology, 1990, Volume: 15, Issue:2

    Topics: Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cilazapril; Coronary Circulation; Coronary Disease; Electrocardiography; Exercise; Heart; Heart Rate; Humans; Male; Middle Aged; Nitriles; Organotechnetium Compounds; Pilot Projects; Prospective Studies; Pyridazines; Radionuclide Imaging

1990

Other Studies

6 other study(ies) available for cilazapril, anhydrous and Coronary Disease

ArticleYear
Effects of cilazapril on endothelial function and pulmonary hypertension in patients with congestive heart failure.
    Japanese heart journal, 2002, Volume: 43, Issue:6

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Circulation; Brachial Artery; Cilazapril; Coronary Disease; Endothelium, Vascular; Female; Heart Failure; Humans; Hypertension, Pulmonary; Male; Middle Aged; Vasodilation

2002
[Effect of cilazapril on myocardial contractility and left ventricular systolic function in hypertensive patients with coronary heart disease and low ejection fraction].
    Cardiology, 1993, Volume: 82 Suppl 2

    Topics: Aged; Cardiac Output, Low; Cilazapril; Coronary Disease; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Myocardial Contraction; Systole; Ventricular Function, Left

1993
Attenuation of heat shock protein expression by coronary occlusion in hypertrophied hearts.
    The American journal of physiology, 1997, Volume: 273, Issue:2 Pt 2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cardiomegaly; Carrier Proteins; Cilazapril; Coronary Disease; Heat-Shock Proteins; HSC70 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; HSP72 Heat-Shock Proteins; Male; Myocardium; Organ Size; Rats; Rats, Wistar; RNA, Messenger; Time Factors

1997
Limitations of angiotensin-converting enzyme inhibitor in restenosis of a deep arterial injury model.
    Japanese circulation journal, 1998, Volume: 62, Issue:1

    Topics: Angioplasty, Balloon; Angiotensin-Converting Enzyme Inhibitors; Animals; Cilazapril; Coronary Disease; Disease Models, Animal; Hyperplasia; Male; Rats; Rats, Sprague-Dawley; Recurrence; Tunica Intima

1998
A dilemma for the 1990s. Choosing appropriate experimental animal model for the prevention of restenosis.
    Circulation, 1992, Volume: 85, Issue:4

    Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Animals; Carotid Stenosis; Cilazapril; Coronary Disease; Disease Models, Animal; Pyridazines; Recurrence; Swine

1992
Redoubtable restenosis.
    Circulation, 1992, Volume: 86, Issue:1

    Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Coronary Disease; Dose-Response Relationship, Drug; Humans; Pyridazines; Recurrence; Research Design

1992